Loading...
Keywords
Last Name
Institution
 Back to Profile

Jennifer Schuster

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiratory Tract Infections
18
2024
85
5.190
 Why?
Influenza, Human
19
2024
68
4.990
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
50
4.110
 Why?
Humans
117
2024
6896
3.810
 Why?
Influenza Vaccines
12
2024
28
3.730
 Why?
Child
83
2024
3364
3.450
 Why?
Enterovirus Infections
12
2023
37
3.300
 Why?
Enterovirus D, Human
11
2023
25
3.080
 Why?
Schools
10
2024
56
2.930
 Why?
Hospitalization
35
2024
210
2.890
 Why?
Child, Preschool
43
2024
1569
2.660
 Why?
United States
40
2024
669
2.480
 Why?
Influenza A Virus, H1N1 Subtype
7
2024
13
2.190
 Why?
Metapneumovirus
9
2022
12
2.180
 Why?
Adolescent
48
2024
2197
2.120
 Why?
Paramyxoviridae Infections
8
2016
12
2.100
 Why?
Antibodies, Viral
9
2024
47
1.950
 Why?
Disease Outbreaks
11
2023
29
1.770
 Why?
Infant
37
2024
1446
1.740
 Why?
Female
42
2024
3525
1.680
 Why?
Male
41
2024
3337
1.600
 Why?
Virus Diseases
3
2024
16
1.550
 Why?
Rhinovirus
5
2023
11
1.520
 Why?
Systemic Inflammatory Response Syndrome
11
2024
18
1.460
 Why?
Respiratory Syncytial Virus Infections
8
2024
50
1.440
 Why?
Prospective Studies
21
2024
525
1.400
 Why?
Vaccination
16
2024
71
1.290
 Why?
Mucocutaneous Lymph Node Syndrome
5
2021
9
1.210
 Why?
Students
3
2024
34
1.160
 Why?
Pandemics
11
2024
82
1.110
 Why?
Vulnerable Populations
2
2023
7
1.030
 Why?
Respiratory Syncytial Virus, Human
4
2024
27
0.930
 Why?
Gastroenteritis
2
2022
28
0.910
 Why?
Antibodies, Neutralizing
5
2021
31
0.830
 Why?
Viruses
2
2022
5
0.830
 Why?
Pneumonia, Viral
3
2020
16
0.810
 Why?
Communicable Diseases
2
2022
8
0.810
 Why?
Case-Control Studies
14
2024
215
0.810
 Why?
Touch
1
2021
1
0.810
 Why?
Vaccines
2
2023
17
0.810
 Why?
School Health Services
1
2022
9
0.810
 Why?
Spike Glycoprotein, Coronavirus
2
2022
19
0.810
 Why?
Respiratory System
1
2021
5
0.800
 Why?
Immunization Schedule
2
2017
10
0.730
 Why?
Asymptomatic Infections
1
2020
3
0.720
 Why?
Antibodies, Monoclonal, Humanized
2
2024
34
0.700
 Why?
Influenza A Virus, H3N2 Subtype
7
2024
12
0.690
 Why?
Adult
12
2024
1181
0.670
 Why?
Seasons
11
2024
35
0.670
 Why?
Asthma
5
2023
157
0.670
 Why?
Immunoglobulins, Intravenous
5
2023
10
0.660
 Why?
Hematologic Diseases
1
2018
4
0.650
 Why?
Immunologic Deficiency Syndromes
1
2018
9
0.650
 Why?
Critical Care
4
2021
13
0.640
 Why?
Picornaviridae Infections
1
2018
21
0.620
 Why?
Communicable Diseases, Emerging
1
2018
3
0.620
 Why?
Communicable Disease Control
1
2018
5
0.620
 Why?
Hyponatremia
1
2017
2
0.610
 Why?
Retrospective Studies
11
2023
1296
0.580
 Why?
Hospitals, Pediatric
8
2024
187
0.570
 Why?
Public Health Practice
1
2016
1
0.560
 Why?
Immunization Programs
1
2016
6
0.560
 Why?
Infectious Disease Medicine
2
2022
4
0.550
 Why?
Neoplasms
1
2018
128
0.540
 Why?
Coronavirus Infections
3
2020
15
0.510
 Why?
Specialization
1
2014
7
0.490
 Why?
Missouri
3
2024
81
0.490
 Why?
Treatment Outcome
6
2021
622
0.470
 Why?
Meningitis, Fungal
1
2013
1
0.450
 Why?
Histoplasma
1
2013
3
0.450
 Why?
Histoplasmosis
1
2013
3
0.450
 Why?
Connective Tissue Diseases
2
2023
4
0.440
 Why?
Immunocompromised Host
2
2024
10
0.420
 Why?
Pediatrics
1
2014
186
0.410
 Why?
Nervous System Diseases
2
2023
13
0.410
 Why?
Prevalence
3
2023
146
0.400
 Why?
Infant, Newborn
9
2024
816
0.400
 Why?
Fever
4
2021
26
0.390
 Why?
Population Surveillance
2
2021
13
0.390
 Why?
Myelitis
2
2022
5
0.390
 Why?
Respiratory Syncytial Virus Vaccines
2
2024
8
0.380
 Why?
Risk Factors
4
2023
487
0.380
 Why?
Longitudinal Studies
3
2020
119
0.380
 Why?
Intensive Care Units
4
2023
17
0.370
 Why?
Infliximab
2
2021
7
0.370
 Why?
Vaccines, Synthetic
4
2022
9
0.360
 Why?
Interferon Type I
2
2022
5
0.340
 Why?
Critical Illness
3
2022
22
0.310
 Why?
Autoantibodies
2
2024
11
0.300
 Why?
Transplant Recipients
2
2024
9
0.290
 Why?
Severity of Illness Index
2
2020
149
0.290
 Why?
Acute Disease
3
2024
79
0.290
 Why?
Glucocorticoids
3
2023
32
0.290
 Why?
Intensive Care Units, Pediatric
2
2024
11
0.290
 Why?
Respiratory Syncytial Viruses
2
2024
18
0.290
 Why?
Animals
6
2016
729
0.290
 Why?
Advisory Committees
2
2017
9
0.290
 Why?
Cross-Over Studies
3
2023
35
0.280
 Why?
International Classification of Diseases
2
2024
10
0.280
 Why?
Length of Stay
4
2020
233
0.270
 Why?
Coinfection
2
2024
7
0.270
 Why?
Pregnancy Complications, Infectious
2
2022
17
0.260
 Why?
Minority Groups
2
2022
17
0.260
 Why?
Cross-Sectional Studies
4
2023
336
0.250
 Why?
Pregnancy
5
2024
216
0.250
 Why?
Molecular Mimicry
1
2024
3
0.240
 Why?
Cross Reactions
1
2024
8
0.240
 Why?
Epitopes
1
2024
20
0.240
 Why?
Antiviral Agents
1
2024
30
0.240
 Why?
Adenoviruses, Human
1
2024
2
0.240
 Why?
Adenovirus Infections, Human
1
2024
4
0.240
 Why?
Disease Models, Animal
2
2014
71
0.240
 Why?
Public Health Surveillance
2
2021
4
0.240
 Why?
School Nursing
1
2024
5
0.240
 Why?
Nurse's Role
1
2024
10
0.230
 Why?
Hemagglutination Inhibition Tests
1
2024
1
0.230
 Why?
Vaccines, Inactivated
1
2024
2
0.230
 Why?
Antibody Formation
1
2024
4
0.230
 Why?
Pneumonia, Mycoplasma
1
2024
15
0.230
 Why?
Risk Assessment
2
2024
137
0.230
 Why?
Central Nervous System Viral Diseases
2
2022
6
0.230
 Why?
Health Knowledge, Attitudes, Practice
1
2024
65
0.230
 Why?
Neuromuscular Diseases
2
2022
7
0.230
 Why?
Echocardiography
3
2020
81
0.230
 Why?
Common Data Elements
1
2023
2
0.230
 Why?
Acceleration
1
2023
4
0.230
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2023
2
0.220
 Why?
Immunoglobulin G
2
2021
34
0.220
 Why?
Respiratory Insufficiency
1
2023
13
0.220
 Why?
Disease Progression
3
2023
111
0.220
 Why?
Educational Status
1
2023
21
0.220
 Why?
Guillain-Barre Syndrome
1
2023
1
0.220
 Why?
Extracorporeal Membrane Oxygenation
1
2023
16
0.220
 Why?
Stroke
1
2023
22
0.210
 Why?
RNA, Messenger
4
2024
115
0.210
 Why?
CD8-Positive T-Lymphocytes
3
2022
15
0.210
 Why?
Enterovirus
1
2023
12
0.210
 Why?
Age Factors
3
2021
210
0.210
 Why?
Regression Analysis
2
2021
52
0.210
 Why?
Neutralization Tests
3
2022
6
0.210
 Why?
Immunity, Maternally-Acquired
1
2022
1
0.210
 Why?
Rotavirus Vaccines
1
2022
14
0.200
 Why?
Rotavirus
1
2022
18
0.200
 Why?
Community-Institutional Relations
1
2022
5
0.200
 Why?
Rotavirus Infections
1
2022
20
0.200
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2020
71
0.200
 Why?
Academic Medical Centers
1
2022
11
0.200
 Why?
Child, Hospitalized
1
2022
26
0.200
 Why?
Disabled Children
1
2022
8
0.200
 Why?
Cohort Studies
4
2024
289
0.200
 Why?
Education, Distance
1
2022
6
0.200
 Why?
Urban Population
1
2022
27
0.200
 Why?
Herpesvirus 1, Cercopithecine
1
2021
2
0.200
 Why?
Young Adult
5
2022
647
0.200
 Why?
Molecular Diagnostic Techniques
2
2021
38
0.200
 Why?
Follow-Up Studies
2
2021
304
0.190
 Why?
Emergency Service, Hospital
4
2024
130
0.190
 Why?
Vaccine Potency
1
2021
7
0.190
 Why?
Ventricular Dysfunction, Left
1
2021
19
0.190
 Why?
Tomography, X-Ray Computed
2
2021
117
0.190
 Why?
Respiration, Artificial
4
2023
17
0.190
 Why?
Mouth
1
2020
3
0.180
 Why?
DNA, Viral
1
2020
13
0.180
 Why?
Monitoring, Physiologic
1
2020
23
0.180
 Why?
Postoperative Care
1
2020
30
0.180
 Why?
Prognosis
1
2020
211
0.170
 Why?
Biomarkers
2
2021
136
0.170
 Why?
Cough
2
2015
7
0.170
 Why?
Mothers
3
2024
33
0.160
 Why?
Metabolic Diseases
1
2018
11
0.160
 Why?
Diagnosis, Differential
2
2021
77
0.160
 Why?
Virus Replication
2
2015
9
0.160
 Why?
Recurrence
2
2021
110
0.160
 Why?
Orthomyxoviridae
1
2018
2
0.160
 Why?
Reassortant Viruses
1
2018
2
0.160
 Why?
Organoplatinum Compounds
1
2017
1
0.150
 Why?
Sodium
1
2017
7
0.150
 Why?
Hypotension
1
2017
5
0.150
 Why?
Influenza B virus
3
2022
22
0.150
 Why?
Magnetic Resonance Imaging
3
2020
122
0.150
 Why?
Patient Acuity
3
2022
7
0.150
 Why?
Yellow Fever Vaccine
1
2017
1
0.150
 Why?
Meningococcal Vaccines
1
2017
2
0.150
 Why?
Herpes Zoster Vaccine
1
2017
2
0.150
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2017
3
0.150
 Why?
Pneumococcal Vaccines
1
2017
4
0.150
 Why?
Hepatitis B Vaccines
1
2017
2
0.150
 Why?
Patient Discharge
3
2022
57
0.150
 Why?
Papillomavirus Vaccines
1
2017
6
0.150
 Why?
Practice Guidelines as Topic
1
2017
108
0.140
 Why?
Mutation
1
2018
212
0.140
 Why?
Societies, Medical
1
2016
51
0.140
 Why?
Replicon
1
2016
1
0.130
 Why?
Virus Internalization
1
2015
1
0.130
 Why?
Recombination, Genetic
1
2015
5
0.130
 Why?
Jordan
1
2015
1
0.130
 Why?
Respiratory Mucosa
1
2015
4
0.130
 Why?
Viral Vaccines
1
2016
10
0.130
 Why?
Tertiary Care Centers
1
2015
11
0.130
 Why?
Vaccines, Virus-Like Particle
1
2015
1
0.130
 Why?
Disease Management
1
2015
34
0.130
 Why?
Community Networks
1
2014
2
0.120
 Why?
Cross Protection
1
2014
1
0.120
 Why?
Lung
1
2015
65
0.120
 Why?
Seroepidemiologic Studies
1
2014
3
0.120
 Why?
Disease Transmission, Infectious
1
2014
4
0.120
 Why?
Emergency Medical Services
1
2014
14
0.120
 Why?
Antibodies, Monoclonal
1
2014
23
0.120
 Why?
Mice, Inbred DBA
1
2014
3
0.120
 Why?
Chemoprevention
1
2014
4
0.120
 Why?
Physicians
1
2014
23
0.120
 Why?
Mice, Inbred BALB C
1
2014
29
0.120
 Why?
Gene Expression Regulation
1
2015
101
0.120
 Why?
Immunotherapy
1
2014
16
0.120
 Why?
Genetic Variation
1
2015
174
0.120
 Why?
Signal Transduction
1
2015
132
0.120
 Why?
Cytopathogenic Effect, Viral
1
2013
2
0.120
 Why?
Virulence
1
2013
7
0.120
 Why?
Opportunistic Infections
1
2013
7
0.120
 Why?
Bronchiolitis
1
2013
10
0.110
 Why?
Leukocytes, Mononuclear
2
2024
16
0.110
 Why?
Predictive Value of Tests
1
2013
99
0.110
 Why?
Polymerase Chain Reaction
1
2013
84
0.110
 Why?
Radiography
1
2013
37
0.110
 Why?
Chronic Disease
1
2013
105
0.110
 Why?
Aftercare
2
2022
5
0.110
 Why?
Brain
1
2013
80
0.110
 Why?
Stroke Volume
2
2023
19
0.100
 Why?
Prisoners
1
2011
1
0.100
 Why?
Vietnam Conflict
1
2011
1
0.100
 Why?
Veterans
1
2011
2
0.100
 Why?
Viral Fusion Proteins
3
2016
4
0.100
 Why?
Stress, Psychological
1
2011
32
0.100
 Why?
Adaptation, Psychological
1
2011
39
0.100
 Why?
Obesity
2
2023
125
0.100
 Why?
Inflammation
2
2023
51
0.100
 Why?
Immunomodulation
2
2021
2
0.090
 Why?
Sulfonylurea Compounds
1
2007
1
0.070
 Why?
Thiazolidinediones
1
2007
1
0.070
 Why?
Hypoglycemic Agents
1
2007
36
0.070
 Why?
Mice
3
2015
348
0.070
 Why?
Drug Therapy, Combination
2
2021
35
0.070
 Why?
Flow Cytometry
2
2015
32
0.060
 Why?
Mice, Inbred C57BL
2
2015
92
0.060
 Why?
Drug Utilization
1
2024
15
0.060
 Why?
Sorting Nexins
1
2024
1
0.060
 Why?
Phosphoproteins
1
2024
14
0.060
 Why?
Hospital Mortality
1
2024
22
0.060
 Why?
T-Lymphocytes
1
2024
31
0.060
 Why?
Transplantation, Homologous
1
2024
19
0.060
 Why?
Focus Groups
1
2024
12
0.060
 Why?
Antibodies, Bacterial
1
2024
8
0.060
 Why?
RNA, Messenger, Stored
1
2023
1
0.060
 Why?
Sensitivity and Specificity
1
2024
150
0.060
 Why?
Reproducibility of Results
1
2024
199
0.060
 Why?
C-Reactive Protein
1
2023
16
0.060
 Why?
Crowding
1
2023
4
0.060
 Why?
Kansas
1
2023
43
0.060
 Why?
Family Characteristics
1
2023
10
0.050
 Why?
Ventricular Function, Left
1
2023
28
0.050
 Why?
Sialic Acid Binding Ig-like Lectin 2
1
2023
1
0.050
 Why?
Research Design
1
2023
63
0.050
 Why?
Receptor, Notch1
1
2023
2
0.050
 Why?
T-Lymphocytes, Regulatory
1
2023
7
0.050
 Why?
NF-kappa B p52 Subunit
1
2022
1
0.050
 Why?
Haploinsufficiency
1
2022
10
0.050
 Why?
NF-kappa B
1
2022
14
0.050
 Why?
Immunity, Cellular
1
2022
18
0.050
 Why?
Adenoviridae
1
2022
6
0.050
 Why?
Oxygen
1
2022
14
0.050
 Why?
Immunity, Humoral
1
2022
14
0.050
 Why?
Antigens, Viral
1
2022
8
0.050
 Why?
Immunoassay
1
2022
10
0.050
 Why?
Policy
1
2022
3
0.050
 Why?
Viral Envelope Proteins
1
2022
3
0.050
 Why?
Vaccines, Attenuated
1
2022
8
0.050
 Why?
Inpatients
1
2023
44
0.050
 Why?
Membrane Glycoproteins
1
2022
14
0.050
 Why?
Immunization, Passive
1
2022
1
0.050
 Why?
Infectious Disease Transmission, Vertical
1
2022
7
0.050
 Why?
Electronic Health Records
1
2023
64
0.050
 Why?
Pilot Projects
1
2022
120
0.050
 Why?
Life Support Care
1
2022
1
0.050
 Why?
Immunization, Secondary
1
2022
2
0.050
 Why?
Saliva
1
2021
10
0.050
 Why?
Surveys and Questionnaires
1
2023
274
0.050
 Why?
Specimen Handling
1
2021
17
0.050
 Why?
Nasopharynx
1
2021
25
0.050
 Why?
Propensity Score
1
2021
8
0.050
 Why?
Shock
1
2021
4
0.050
 Why?
Combined Modality Therapy
1
2021
46
0.050
 Why?
Logistic Models
1
2021
84
0.050
 Why?
Comorbidity
1
2021
56
0.050
 Why?
Clinical Laboratory Techniques
1
2020
9
0.050
 Why?
Hospital Costs
1
2020
29
0.050
 Why?
Middle Aged
2
2015
608
0.040
 Why?
Time Factors
1
2020
250
0.040
 Why?
Cancer Vaccines
1
1999
2
0.040
 Why?
Lymphatic Metastasis
1
1999
3
0.040
 Why?
Lymph Nodes
1
1999
3
0.040
 Why?
Drug Resistance
1
2019
7
0.040
 Why?
Inflammation Mediators
1
2019
8
0.040
 Why?
Comparative Effectiveness Research
1
2019
6
0.040
 Why?
Kidney Neoplasms
1
1999
11
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2019
12
0.040
 Why?
Multicenter Studies as Topic
1
2019
19
0.040
 Why?
Melanoma
1
1999
12
0.040
 Why?
Breast Neoplasms
1
1999
38
0.040
 Why?
Randomized Controlled Trials as Topic
1
2019
55
0.040
 Why?
Materials Testing
1
1998
1
0.040
 Why?
Aerosols
1
1998
4
0.040
 Why?
Nebulizers and Vaporizers
1
1998
8
0.040
 Why?
Drug Delivery Systems
1
1998
5
0.040
 Why?
Practice Patterns, Nurses'
1
2017
5
0.040
 Why?
Aged
2
2015
378
0.040
 Why?
Algorithms
1
2017
105
0.040
 Why?
Practice Patterns, Physicians'
1
2017
85
0.040
 Why?
Alphavirus
1
2016
1
0.030
 Why?
Encephalitis Virus, Venezuelan Equine
1
2016
1
0.030
 Why?
Bronchoalveolar Lavage Fluid
1
2016
12
0.030
 Why?
Sequence Homology
1
2015
2
0.030
 Why?
Bronchi
1
2015
1
0.030
 Why?
Endosomes
1
2015
1
0.030
 Why?
Genome, Viral
1
2015
4
0.030
 Why?
Molecular Epidemiology
1
2015
6
0.030
 Why?
Evolution, Molecular
1
2015
6
0.030
 Why?
Nose
1
2016
7
0.030
 Why?
Transfection
1
2015
22
0.030
 Why?
Microscopy, Confocal
1
2015
19
0.030
 Why?
Phylogeny
1
2015
24
0.030
 Why?
RNA, Small Interfering
1
2015
22
0.030
 Why?
Dyspnea
1
2015
4
0.030
 Why?
Illinois
1
2015
5
0.030
 Why?
Colorado
1
2015
9
0.030
 Why?
Molecular Sequence Data
1
2015
71
0.030
 Why?
Respiratory Sounds
1
2015
6
0.030
 Why?
Cluster Analysis
1
2015
43
0.030
 Why?
Cell Line
1
2015
81
0.030
 Why?
Lymphocyte Depletion
1
2015
1
0.030
 Why?
Programmed Cell Death 1 Receptor
1
2015
4
0.030
 Why?
Viral Matrix Proteins
1
2015
2
0.030
 Why?
HEK293 Cells
1
2015
32
0.030
 Why?
Macaca mulatta
1
2015
24
0.030
 Why?
Mice, Transgenic
1
2015
35
0.030
 Why?
Aged, 80 and over
1
2015
151
0.030
 Why?
Sequence Analysis, DNA
1
2015
115
0.030
 Why?
Receptors, Virus
1
2015
2
0.030
 Why?
Antigen-Presenting Cells
1
2015
2
0.030
 Why?
Analysis of Variance
1
2015
22
0.030
 Why?
Oximetry
1
2015
8
0.030
 Why?
Mice, Knockout
1
2015
59
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2015
99
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
41
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2011
4
0.030
 Why?
Interviews as Topic
1
2011
20
0.030
 Why?
Cerebral Infarction
1
1990
1
0.020
 Why?
Hand
1
1990
3
0.020
 Why?
Movement
1
1990
7
0.020
 Why?
Therapeutic Equivalency
1
2007
5
0.020
 Why?
Biological Availability
1
2007
8
0.020
 Why?
Drug Combinations
1
2007
19
0.020
 Why?
Area Under Curve
1
2007
35
0.020
 Why?
Sex Factors
1
2007
68
0.020
 Why?
Equipment Design
1
1998
14
0.010
 Why?
Administration, Inhalation
1
1998
19
0.010
 Why?
Frontal Lobe
1
1990
1
0.010
 Why?
Corpus Callosum
1
1990
5
0.010
 Why?
Accidents, Traffic
1
1990
18
0.010
 Why?
Craniocerebral Trauma
1
1990
18
0.010
 Why?
Schuster's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_